Immortagen, Inc. is a cancer diagnostics company and University of Iowa spin-off venture developing cutting-edge clinical decision support technologies. A major ongoing R&D project is to develop algorithms to guide selection of the most effective targeted anti-cancer treatments based on next generation sequencing data.

We are seeking a motivated bioinformatician to join our research team. Candidates should have a Master’s degree or higher in computer science, informatics or bioinformatics with at least one year of experience in computational genomics. Prior experience in the analysis of tumor next generation sequencing data is highly desirable. Immortagen will offer a competitive salary, potential stock options, healthcare stipend, and other benefits.

Please contact for more details.

< Home